Overall, these results suggest that along the activation/differentiation program of anti-tumor T cells, Suv39h1-dependent silencing of the IFN-I response and of pathways of the exhaustion program, imposes an epigenetic barrier that prevents re-programing of TILs towards a terminally exhausted program by anti-PD-1. This evidence concerns the gene SUV39H1 and neoplasm.